An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.

PHASE2RecruitingINTERVENTIONAL

Enrollment

136

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

April 30, 2027

Study Completion Date

December 31, 2027

Conditions

Colorectal CancerCRC (Colorectal Cancer)Cancer Cachexia

Interventions

DRUG

NGM120 Q4W

NGM120 given subcutaneously every 4 weeks

DRUG

NGM120 Q8W

NGM120 given subcutaneously every 8 weeks

DRUG

Placebo given

Placebo given subcutaneously every 4 weeks

Trial Locations (1)

RECRUITING

NGM Clinical Study Site, Laredo